Concepedia

Jacob A. Kaizerman

JA

Statistics

Publications

15

Citations

802

H-Index

15

Active since

2002

Affiliations

Amgen (United States)(Current)

Sunesis (United States)

Jacob A. Kaizerman is an author at Amgen (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2002–2014

15

Publications

15

Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs

Hailong Jiao, Jacob A. Kaizerman, Timothy F. Stanton et al. · Journal of Medicinal Chemistry · 2008 · 239 citations

, , +17

DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 1: Internal benzimidazole derivatives

Roland W. Bürli, Dustin L. McMinn, Jacob A. Kaizerman et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 128 citations

, , +14

Discovery of AMG 925, a FLT3 and CDK4 Dual Kinase Inhibitor with Preferential Affinity for the Activated State of FLT3

Zhihong Li, Xianghong Wang, John Eksterowicz et al. · Journal of Medicinal Chemistry · 2014 · 72 citations · Full text

, , +16

DNA Binding Ligands Targeting Drug-Resistant Bacteria:  Structure, Activity, and Pharmacology

Jacob A. Kaizerman, Matthew Gross, Yigong Ge et al. · Journal of Medicinal Chemistry · 2003 · 68 citations

, , +17

DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 2: C-terminal benzimidazoles and derivatives

Roland W. Bürli, Peter Jones, Dustin L. McMinn et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 56 citations

, , +14

1–5 of 15